Medical devices, healthcare technology and the business of care
510(k) clearance · K263567

PICO 7 Single Use Negative Pressure Wound Therapy System;PICO 14 Single Use Negative Pressure Wound Therapy System;PICO Fluid Management Packs

Smith and Nephew Medical Limited · Decision date Nov 6, 2026

MEDTECHLEDGER EXPLANATIONK263567

What did the FDA decide?

FDA recorded a substantially equivalent decision for K263567 on 2026-11-06, covering the PICO 7 Single Use Negative Pressure Wound Therapy System, the PICO 14 Single Use Negative Pressure Wound Therapy System and PICO Fluid Management Packs, submitted by Smith and Nephew Medical Limited. The application was received 09/30/2026 and falls under product code QFC, with OMP listed as a subsequent product code, in the General & Plastic Surgery specialty and review panel. Substantial equivalence is a 510(k) clearance, not a PMA approval.

The record identifies the submission as type Special, not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. The public listing does not state which components were changed or the basis for equivalence, so the specific modifications and any supporting performance data remain unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Nov 6, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263567
Regulatory pathway
510(k) premarket notification
Product code
QFC
Decision code
SESE
Decision date
Nov 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Negative Pressure Wound Therapy Device For Reduction Of Wound Complications.

Product code
QFC
FDA device class
2

FDA decision timeline

  1. K263567 received

    Application receipt date recorded by FDA.

  2. K263567 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Smith and Nephew Medical Limited

Headquarters
Not reported
Brand website
smith-nephew.com
FDA applicant address
Kingston Upon Hull

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records